UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 24, 2022
Accession Number: 0001437749-22-012862
Submission Type: POS AM
CIK: 0000810509
Company Name: NAVIDEA BIOPHARMACEUTICALS, INC.
File Number: 333-184173